Alterity Therapeutics ATHE
NASDAQ ATHE
$4.59 +0.14 (+3.26%)
As of: Aug 21, 2026 · 11:02 AM EDT

Alterity Therapeutics (ATHE) EPS (Diluted) (2009 - 2024)

Alterity Therapeutics (ATHE) EPS (Diluted) (2009 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 140.14 Bn 132.29 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 87.02 Bn 79.03 Bn 3.93 Bn 12.23
3 Argenx Se 65.30 Bn 60.12 Bn 1.37 Bn 7.33
4 Moderna 60.84 Bn 55.70 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.15 Bn 37.06 Bn 1.53 Bn 2.05
6 Alnylam Pharmaceuticals 31.49 Bn 28.18 Bn 992.69 Mn 1.19
7 BioNTech SE 28.78 Bn 10.38 Bn 668.28 Mn -0.72
8 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.14 Bn 26.31 Bn - 0.15
10 Alterity Therapeutics 49.58 Mn 17.27 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 0.00
Jun 30, 2023 0.00
Jun 30, 2022 -0.04
Dec 31, 2019 -1.42
Jun 30, 2019 -3.24
Dec 31, 2018 -1.41
Jun 30, 2018 -2.34
Dec 31, 2017 -1.02
Jun 30, 2017 -1.98
Dec 31, 2016 -1.01
Jun 30, 2010 -1.59
Jun 30, 2009 -2.10